CYP2A6 phenotype in a Spanish population:: Influence of gender, age and smoking

被引：0
|
作者：
Carcas de Benavides, C. [1 ]
Fanlo Villacampa, A. [1 ]
Soriano Guillén, A. [1 ]
Vicente Romero, J. [1 ]
Arenaz Villalba, I. [1 ]
Mayayo Dehesa, E. [1 ]
Sinués Porta, B. [1 ]
机构：
[1] Univ Zaragoza, Sch Med, Pharmacol Unit, E-50009 Zaragoza, Spain
来源：
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY | 2006年 / 99卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：53 / 54
页数：2
相关论文
共 50 条
  • [21] Genetic polymorphism of CYP2A6 in the German population
    Bourian, M
    Gullstén, H
    Legrum, W
    TOXICOLOGY, 2000, 144 (1-3) : 129 - 137
  • [22] Polymorphisms of nicotine metabolism genes CYP2A6 and CYP2B6 and their effect on smoking addiction in chinese han population
    Wang, Hongjuan
    Fu, Yaning
    Chen, Huan
    Liu, Tong
    Han, Shulei
    Hou, Hongwei
    Hu, Qingyuan
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2020, 127 : 35 - 35
  • [23] CYP2A6 polymorphisms are associated with nicotine dependence and influence withdrawal symptoms in smoking cessation
    Kubota, T
    Nakajima-Taniguchi, C
    Fukuda, T
    Funamoto, M
    Maeda, M
    Tange, E
    Ueki, R
    Kawashima, K
    Hara, H
    Fujio, Y
    Azuma, J
    PHARMACOGENOMICS JOURNAL, 2006, 6 (02): : 115 - 119
  • [24] CYP2A6 polymorphisms are associated with nicotine dependence and influence withdrawal symptoms in smoking cessation
    T Kubota
    C Nakajima-Taniguchi
    T Fukuda
    M Funamoto
    M Maeda
    E Tange
    R Ueki
    K Kawashima
    H Hara
    Y Fujio
    J Azuma
    The Pharmacogenomics Journal, 2006, 6 : 115 - 119
  • [25] Characterization of a novel CYP2A7/CYP2A6 hybrid allele (CYP2A6*12) that causes reduced CYP2A6 activity
    Oscarson, M
    McLellan, RA
    Asp, V
    Ledesma, M
    Ruiz, MLB
    Sinues, B
    Rautio, A
    Ingelman-Sundberg, M
    HUMAN MUTATION, 2002, 20 (04) : 275 - 283
  • [26] Functional Characterization of Cytochrome P450 2A6 Allelic Variants CYP2A6*15, CYP2A6*16, CYP2A6*21, and CYP2A6*22
    Tiong, Kai Hung
    Yiap, Beow Chin
    Tan, Eng Lai
    Ismail, Rusli
    Ong, Chin Eng
    DRUG METABOLISM AND DISPOSITION, 2010, 38 (05) : 745 - 751
  • [27] Ethnic variation in CYP2A6*7, CYP2A6*8 and CYP2A6*10 as assessed with a novel haplotyping method
    Mwenifumbo, JC
    Myers, MG
    Wall, TL
    Lin, SK
    Sellers, EM
    Tyndale, RF
    PHARMACOGENETICS AND GENOMICS, 2005, 15 (03): : 189 - 192
  • [28] Characterization of novel CYP2A6 polymorphic alleles (CYP2A6*18 and CYP2A6*19) that affect enzymatic activity
    Fukami, T
    Nakajima, M
    Higashi, E
    Yamanaka, H
    Sakai, H
    McLeod, HL
    Yokoi, T
    DRUG METABOLISM AND DISPOSITION, 2005, 33 (08) : 1202 - 1210
  • [29] Associations of CYP2A6 genotype with smoking behaviors in southern China
    Liu, Tao
    David, Sean P.
    Tyndale, Rachel F.
    Wang, Hui
    Zhou, Qian
    Ding, Peng
    He, Yan-Hui
    Yu, Xue-Qing
    Chen, Wei
    Crump, Casey
    Wen, Xiao-Zhong
    Chen, Wei-Qing
    ADDICTION, 2011, 106 (05) : 985 - 994
  • [30] Decreasing smoking behaviour and risk through CYP2A6 inhibition
    Sellers, EM
    Tyndale, RF
    Fernandes, LC
    DRUG DISCOVERY TODAY, 2003, 8 (11) : 487 - 493
12345